US mortality has declined over the past 25 years, according to a new report.
Reducing smoking has been less death. Early detection and treatment advances have also had a positive impact, experts say.
But it's not good news. The deaths associated with obesity have increased and prostate cancer has not diminished, said Rebecca Siegel, author of the American Society Against Cancer journal, posted on Tuesday.
Cancer death remains the second cause in the country. The society expects more than 1.7 million cancer cases this year and more than 600,000 deaths in the United States.
The detail of the report is as follows:
Recent reports on the death rates in the United States have recently been reported. In 2017, deaths were seven of the top 10 reasons, according to a government-published report. However, cancer has been positive.
The country's cancer mortality rate has increased to the 1990s. Since then, it has declined, with a drop of 27% between 1991 and 2016.
Lung cancer is the main reason. In cancer, more death has occurred, especially in men. But the death rate for lung cancer was reduced by almost 50% in 1991 among males. The number of smokers began in the 1960s was diminished, Siegel said.
The report has mixed news about prostate cancer, the second largest cause of male mortality.
The rate decreased more than two decades, but according to experts, changes to the 2011 US Preventative Services Task Force have changed, recommending regular trials to stop men using PSA blood test. This decision was concerned that the study had led to unnecessary and excessive diagnosis and treatment.
The mortality rate has changed between 2013 and 2016. Therefore, although the PSA study has not given treatment, it can also prevent some deaths.
With regard to the most common cancers in the United States, those with higher mortality rates are associated with obesity, including pancreas and uterus.
Another is liver cancer. The deaths associated with liver cancer have increased since 1970, and in the beginning, almost all the increases in the use of hepatitis C were infections. However, obesity is now one third of liver cancer and affects more than hepatitis, he said.
An increasing epidemic epidemic was identified as a problem in the 1990s. Ten years before we can learn about how the risk factor influences cancer rates, "maybe, perhaps, how we're seeing the ice tip, cancer obesity, the epidemic," said Siegel.
The decline in the historic gap of the minimum historical mortality has been exacerbated, but now there is an economic gap that spreads, especially in the case of treatment and early detection, better nutrition and the prevention of less-frequent smoking.
In the early 1970s, in the poorer counties, the death rate for colon cancer was 20% lower in rich countries; Now it's 30% bigger. Anti-cancer deaths are rising twice in poorer regions for women, compared to women in the rich countries. Death rates for lung and liver cancer are a 50% increase in poor regions.
Dr. Darrell Gray, Deputy Director of the Oncology Health Center at Ohio University, said the findings are "important, but not surprising."
"We know for some time being the race," said the delegation of other factors, such as appointing or paying poverty and difficulties with doctors, he said.